FDA Inspection 1306222 — Blood Assurance, Inc.
The FDA completed an inspection of Blood Assurance, Inc. on February 20, 2026 in Chattanooga, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 20, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Chattanooga, TN (United States)